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improvement. 1 patient progressed and have required salvage treatment. None of them have presented nor acute toxicity neither
chronic toxicity.
Conclusion. Radiotherapy prevents disease progression for early-stage Dupuytren’s contracture. This way we can avoid new
surgical procedures.
http://dx.doi.org/10.1016/j.rpor.2013.03.394
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Introduction. Ledderhose’s disease or plantar ﬁbromatosis is a proliferative disorder affecting connective tissue of the plantar fas-
cia, it is very similar to Dupuytren’s disease that affects the hands. It is characterized by the appearance of painful subcutaneous
ﬁbrous nodules that may difﬁcult the walk. Treatments include corticoids and surgery with disappointing results. The rate of
recurrence after surgery is high 30–50%. There are not many references in the literature1,2 about irradiation treatment of this
disease. It is not established dose or regimes of treatment at the present. Objectives: To report our experience with ﬁve patients
treated with irradiation.
Methods. Between September 2011 and September 2012 ﬁve patients with Ledderhose’s disease were referred to our department.
They were treated with direct electron ﬁeld with a total dose of 30Gy, 3Gy fraction.
Results. The mean age was 44.5 years (30–53 years), three women and two men. There has been no progression after treatment.
Responses were obtained in the two males, one complete remission and 90% response respectively, with complete disappearance
of pain (40%). In the remaining three patients stable disease without clinical improvement (60%) were observed. There has been
no acute or late toxicity.
Conclusions. Although the follow up and number of patients are small, the observed results are similar to published series in the
literature (24 and 25 patients respectively). Radiotherapy is an effective treatment, and complete remission can be obtained for
both pain and the tumor.
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Introduction. Castleman disease (CD) is a rare benign disorder characterised by hyperplasia of lymphoid tissue that may develop at
a single site (unicentric) or throughout the body (multicentric). It involves hyperproliferation of certain B cells that often produce
cytokine IL-6. Surgery remains themain treatment for resectable unicentric CD, since removal of the largenode is possiblewithout
further complications. No consensus has been reached concerning the most adequate treatment for irresectable unicentric CD.
Objective. Case report description of a unresectable unicentric CD with a successful response after radiotherapy.
Methods. The patient was a 24-year-old man with a nephrotic syndrome becasue of mesangial proliferative glomerulonephritis.
FDG-PET/CT found a right hiliar mass of 3.5 cm of diameter. Open thoracotomy showed inﬁltration of the right pulmonary artery
and superior pulmonary vein requiring a neumonectomy. Histopathological analysis of the tumor showed hyaline vascular type
of CD. The patient was transferred to our department. Radiotherapy treatment was performed with 3DRT (6Mv) giving 46Gy
(200 cGy/fraction).
Results. CT showed a progressive reduction of the mass at 3 and 6 months, with complete remission at 12 months. Patient was
asymptomatic without late effects and without nephrotic syndrome.
Conclusion. Radiotherapy should be considered in case of an unresectable unicentric CD.
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